MDR-1, Bcl-xL, H. pylori, and Wnt/β-catenin signalling in the adult stomach: How much is too much?

Laboratory Investigation

Volumn 92, Issue 12, 2012, Pages 1670-1673

  MacLeod, R John ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BCL XL; WNT PROTEIN;

ADENOMA; APOPTOSIS; CANCER CELL CULTURE; CELL MEMBRANE; CHRONIC GASTRITIS; COLON CANCER; COLON POLYPOSIS; GENE SILENCING; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; WNT SIGNALING PATHWAY;

BCL-X PROTEIN; CELL SURVIVAL; FEMALE; HUMANS; MALE; P-GLYCOPROTEIN; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84870432751     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.151     Document Type: Review

References (28)

1. Chen KG, Sikic BI. Molecular pathways: regulation and therapeutic implications of multidrug resistance. Clin Cancer Res 2012;18:1863-1869.
2. Rocco A, Compare D, Liguroi E, et al. MDR1-P-lgycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells. Lab Invest (in press).
3. Asciutti S, Akiri G, Grumolato L, et al. Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells. Oncogene 2011;30:956-966.
4. Yamada T, Takaoka AS, Naishiro Y, et al. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res 2000;60:4761-4766.
5. Clevers H, Nusse R. Wnt/b-catenin signaling and disease. Cell 2012;149:1192-1205.
6. Snippert HJ, Clevers H. Tracking adult stem cells. EMBO Rep 2011;12:113-122.
7. Kikuchi A, Yamamoto H, Sato A, et al. Wnt5a: its signaling, functions and implications in diseases. Acta Physiol 2012;204:17-33.
8. Li VSW, Ng SS, Boersema PJ, et al. Wnt signaling through inhibition of b-Catenin degradation in an intact Axin1 complex. Cell 2012;149:1245-1256.
9. Taelman VF, Dobrowoiski R, Piouhinec JL, et al. Wnt signaling requires sequestration of glycogen synthase kinase-3 inside multivesicular endosomes. Cell 2010;143: 1136-1148.
10. Radulescu S, Ridgway RA, Cordero J, et al. Acute Wnt signaling activation perturbs differentiation within the adult stomach and rapidly leads to tumor formation. Oncogene, published online 4 June 2012; doi:10.1038/onc.2012.224.
11. Zhang H, Xue Y. Wnt pathway is involved in advanced gastric carcinoma. Hepatogastroenterology 2008;55: 1126-1130.
12. 2 pathway. Gastroentero-logy 2006;131:1086-1095.
13. Kurayoshi M, Oue N, Yamamoto H, et al. Expression of Wnt5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006;66:10439-10448.
14. Nishita M, Enomoto M, Yamagata K, et al. Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells. Trends Cell Biol 2010;20:346-354.
15. Hanaki H, Yamamoto H, Sakane H, et al. An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis. Mol Cancer Ther 2011;112:298-307.
16. MacLeod RJ, Hayes M, Pacheco I. Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells. Am J Physiol 2007;293:G403-G411.
17. Polk DB, Peek RM. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010;10:403-414.
18. Gnad T, Feoktistova M, Leverkus M, et al. Helicobacter pylori-induced activation of b-catenin involves low density lipoprotein receptor-related protein 6 and Dishevelled. Mol Cancer 2010;9:31.
19. Oguma K, Oshima H, Aoki M, et al. Activated macrophages promote Wnt signaling through tumour necrosis factor-a in gastric tumour cells. EMBO J 2008;27: 1671-1681.
20. Popivanova BK, Kitamura K, Wy Y, et al. Blocking TNF-a in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008;118:560-570.
21. Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009;15:1126-1132.
22. Abrol R, Edderkaoui M, Goddard III WA, et al. Molecular basis for the interplay of apoptosis and proliferation mediated by Bcl-xL: Bim interactions in pancreatic cancer cells. Biochem Biophys Res Commun 2012;422:596-601.
23. Goldsmith KC, Gross M, Peirce S, et al. Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastoma. Cancer Res 2012;72: 2565-2577.
24. Baker N, Huch M, Kujala P, et al. Lgr5 (+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010;6:25-36.
25. Schuijers J, Clevers H. Adult mammalian stem cells: the role of Wnt, Lgr5 and R-spondins. EMBO J 2012;31: 2685-2696.
26. Polakis P. Drugging Wnt signaling in cancer. EMBO J 2012;31:2737-2746.
27. Janda CY, Waghray D, Levin AM, et al. Structural basis of Wnt recognition by Frizzled. Science 2012;337:59-64.
28. Augustin I, Goidts V, Bangers A, et al. The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis. EMBO Mol Med 2012;4:38-51.